Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device Exits Can Rival Biotech, But Watch Out for the Risks

This article was originally published in Start Up

Executive Summary

A look at recent exits challenges the widely held view that device investments have lower return potential than biotech investments. However, a close inspection of the risk/return profile reveals that device investors are taking on more risk than ever.
Advertisement

Related Content

Divide Growing Between Strong, Weak Medical Device IPO Companies
Thriving When The Device IPO Window Closes
PFO Closure: Challenges and Opportunities
PFO Closure: Challenges and Opportunities
Neuro Device Start-Ups Continue to Cause Headaches
Neuro Device Start-Ups Continue to Cause Headaches
Trends for the New Year: Can Medtech Build on the Success of 2007?
CoreValve: A Surgeon Moves Heart Valves to the Cath Lab
Novacept: A Patient Device Exit Strategy Succeeds

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT037575

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel